Company Data
Elevation Oncology Inc.
Ticker
ELEV
Current Price
$0.6772 0.82%
Market Cap
$40.0M
Price Target
Refer to Report
Volume
1.7M
52wk Range
$0.5 - $5.8299
Overview
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.